Body Text
Competitive advantage
- World-first patented technology to recursively weave textiles with mechanical gradients and patterns emulating nature’s own
- Unique patent technology to engineer and manufacture composites comprising engineered textiles and smart matrix
Impact
- Addresses the current shortcomings of implantables including surgical meshes, stents and surgical reconstruction implants
- Enables novel drug delivery strategies for combination devices, dressings and implants
Successful outcomes
- Preclinical testing underway for implants and wearables
Capabilities and facilities
- Prototyping and tech innovation facility at partner start-up in NSW
Our partners
- TissuTex Pty. Ltd., NSW Australia
- Food and Drug Administration, USA
- National Institutes of Health, USA
- Cleveland Clinic, USA
- Case Western Reserve University, USA
- Stanford University School of Medicine and D School, USA
- University of Lund, Sweden
- Ludwig Maximilians University, Germany
- Christopher Columbus Foundation - US Chamber of Commerce
- Wallace Coulter Foundation, USA
- AO Research and Development Institute, Switzerland